Methylation hot spots in the 5' flanking region denote silencing of the O6-methylguanine-DNA methyltransferase gene

Cancer Research

Volumn 57, Issue 17, 1997, Pages 3672-3677

  Qian, Xilin C ^b   Brent, Thomas P ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE;

ARTICLE; CELL POPULATION; CYTOTOXICITY; DNA FLANKING REGION; DNA REPAIR; ENZYME ANALYSIS; GENE SEQUENCE; HUMAN; HUMAN CELL; MARKER GENE; METHYLATION; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REPORTER GENE; SILENCER GENE; TATA BOX;

CPG ISLANDS; DNA METHYLATION; ENZYME REPRESSION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HT29 CELLS; HUMANS; METHYLTRANSFERASES; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; SEQUENCE ANALYSIS, DNA; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0030823671     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. 6-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogenic and therapeutic agents. Cancer Res., 50: 6119-6129, 1990.
2. 6-methylguanine in a synthetic DNA polymer by an inducible activity in Escherichia coli. Biochem. Biophys. Res. Commun., 97: 654-659, 1980.
3. 6-methylguanine to a protein cysteine residue. J. Biol. Chem., 255: 10569-10571, 1980.
4. Day, R. S., III, Ziolkowski, C. H., Scudiero, D. A., Meyer, S. A., Lubiniecki, A. S., Girardi, A. J., Galloway, S. M., and Bynum, G. D. Defective repair of alkylated DNA by human tumor and SV40-transformed human cell strains. Nature (Lond.), 288: 724-727, 1980.
5. 6-methylguanine-DNA methyltransferase gene MGMT in MER+ and MER-human tumor cells. Cancer Res., 50: 7908-7911, 1990.
6. 6-methylguanine DNA methyltransferase (MGMT) mRNA levels in Mer+ and Mer-human tumor cell lines containing the MGMT gene by the polymerase chain reaction technique. Cancer Commun., 2: 13-20, 1990.
7. 6-methylguanine-DNA methyltransferase expression in human rhabdomyosarcoma cell lines and xenografts. Oncol. Res., 4: 167-174, 1995.
8. 6-methylguanine-DNA methyltransferase (MGMT) expression in Mer-human tumor cell lines. Carcinogenesis (Lond.), 16: 2255-2257, 1995.
9. 6-methylguanine-DNA methyltransferase gene. Nucleic Acids Res., 19: 6163-6167, 1991.
10. 6-methylguanine-DNA methyltransferase promoter activity in Mer+ and Mer-cells. Cancer Res., 52: 6404-6406, 1992.
11. 6-methylguanine-DNA methyltransferase promoter reduces transcription. Biochim. Biophys. Acta, 1217: 141-146, 1994.
12. 6-methylguanine-DNA methyltransferase. Mutat. Res. DNA Repair, 293: 119-132, 1993.
13. 6-methylguanine-DNA methyltransferase promoter: correlation with gene suppression. Carcinogenesis (Lond.), 16: 1385-1390, 1995.
14. 6-methylguanine-DNA methyltransferase. Carcinogenesis (Lond.), 15: 577-582, 1994.
15. Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G., Smith, J. A., and Struhl, K. (eds.). Current Protocols in Molecular Biology, pp. 2.2.1-2.2.2. New York: John Wiley & Sons, 1991.
16. Frommer, M., McDonald, L. E., Millar, D. S., Collis, C. M., Watt, F., Grigg, G. W., Molloy, P. L., and Paul, C. L. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc. Natl. Acad. Sci. USA, 89: 1827-1831, 1992.
17. Raizis, A. M., Schmitt, F., and Jost, J-P. A bisulfite method of 5-methyleytosine mapping minimizes template degradation. Anal. Biochem., 226: 161-166, 1994.
18. Clark, S. J., Hairison, J., Paul, C. L., and Frommer, M. High sensitivity mapping of methylated cytosines. Nucleic Acids Res., 22: 2990-2997, 1994.
19. - cells. Carcinogenesis (Lond.), 16: 1857-1863, 1995.
20. Albini, A., Tofferetti, J., Zhu, Z,. Chader, G. J., and Noonan, D. M. Hypomethylation of the interphotoreceptor-retinoid binding protein promoter and the first exon is linked to expression of the gene. Nucleic Acids Res., 18: 5181-5187, 1990.
21. Yen, P., Patel, P., Chinault, A., Mohandas, T., and Shapiro, L. Differential methylation of hypoxanthine phosphoribosyl transferase genes on active and inactive human X chromosomes. Proc. Natl. Acad. Sci. USA, 80: 1759-1763, 1984.
22. Wolf, S., Jolly, D., Lunnen, K., Friedman, T., and Migeon, B. Methylalion of the hypoxanthine phosphoribosyltransferase locus on the human X chromosome: implications for X-chromosome inactivation. Proc. Natl. Acad. Sci. USA, 81: 2806-2810, 1984.
23. Toniolo, D., Martini, G., Migeon, B., and Dono, R. Expression of the GGPD locus on the human X chromosome is associated with demethylation of three CpG islands within 100 kb of DNA. EMBO J. 7: 401-406, 1988.
24. Pfeifer, G., Tanguay, R., Steigerwald, S., and Riggs, A. In vivo footprinting and methylalion analysis by PCR-aided genomic sequencing: comparison of active and inactive X-chromosomal DNA at the CpG island promoter of human PGK-1. Genes Dev., 4: 1277-1297, 1990.
25. 6-methylguanine-DNA methytransferase gene correlates with MGMT expression in human glioma cells. J. Biol. Chem., 269: 17228-17237, 1994.
26. Pieper, R. O., Patel, S., Ting, S. A., Futscher, B. W., and Costello, J. F. Methylation of CpG island transcription factor binding sites is unnecessary for aberrant silencing of the human MGMT gene. J. Biol. Chem., 271: 13916-13924, 1996.
27. Comb, M., and Goodman. H. M. CpG methylalion inhibits proenkephalin gene expression and the binding of the transcription factor AP2. Nucleic Acids Res., 18: 3975-3982, 1990.
28. Iguchi-Ariga, S. M., and Schaffner, W. CpG methylation of the cAMP-responsive enhancer/promoter sequence TGACGTCA abolishes specific factor binding as well as transcriptional activation. Genes Dev., 3: 612-619, 1989.
29. Wang, R. H., Zhang, X. Y., Khan, R., Zhou, Y., Huang, L. H., and Ehrlich, M. Methylated DNA-binding protein from human placenta reeognizes specific methylated sites on several prokaryotic DNAs. Nucleic Acids Res., 14: 9843-9860, 1986.
30. Zhang, X. Y., Asiedu, C. K., Supaker, P. C., Khan, R., Ehrlich, K. C., and Ehrlich, M. Binding sites in mammalian genes and viral gene regulatory regions by methylated DNA-binding protein. Nucleic Acids Res., 18: 6253-6260, 1990.
31. Meehan, R. R., Lewis, J. D., McKay, S., Kleiner, E. L., and Bird, A. P. Identification of a mammalian protein that binds specifically to DNA containing methylated CpGs. Cell, 58: 499-507, 1989.
32. Boyes, J., and Bird, A. DNA methylation inhibits transcription indirectly via a methyl-CpG binding protein. Cell, 64: 1123-1134, 1991.
33. Boyes, J., and Bird, A. Repression of genes by DNA methylation depends on CpG density and promoter strength: evidence for involvement of a methyl-CpG binding protein. EMBO J., 11: 327-333, 1992.
34. 6-methylguanine-DNA methyltransferase gene in human glioma cell lines. Mol. Cell. Biol. 14: 6515-6521, 1994.
35. Macleod, D., Charlton, J., Mullins, J., and Bird, A. P. SP1 sites in the mouse aprt gene promoter are required to prevent methylation of the CpG island. Genes Dev., 8: 2282-2292, 1994.
36. 6-methylguanine-DNA methyltransferase binding protein in DNA repair deficient human cells. Proc. Natl. Acad. Sci. USA, 94: 4348-4353, 1997.